Lung Cancer Care Quality Improvement Study
Part of Cancer, Lungs & breathing clinical trials.
This study helps hospitals use the latest lung cancer guidelines better. If you have NSCLC or ES-SCLC and haven't had recent treatment, this trial may help improve the quality of care you receive.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are receiving care at a large, top-level hospital (Tier 3) in China.
- You have been diagnosed with non-small cell lung cancer (NSCLC) or extensive-stage small cell lung cancer (ES-SCLC).
- You have not had any cancer treatment for your lung cancer, or any previous treatments ended more than 12 months ago.
- You are able to take care of yourself (performance score 0–2): from fully active to up and about more than half the day.
- Your doctor expects you to live at least 3 months.
- You are not planning to switch hospitals for cancer treatment within the next 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects real-world information about people with lung cancer who get newer kinds of cancer drugs. It aims to understand how these innovative therapies work in everyday care and help future research.
This trial is looking at how well a lung cancer treatment improves survival. It enrolls adults with confirmed lung cancer who can safely take the study medicines and have cancer that can be measured on scans.
This trial is a registry that collects information from people with certain types and stages of lung cancer. It helps researchers understand how these cancers are managed in real life, which can guide better future care.
This is an observational study of people with lung cancer. The goal is to better understand care patterns and outcomes; joining would involve giving consent and answering study questions.
This study follows adults with confirmed lung cancer as they are diagnosed and treated in routine clinical practice. It aims to better understand how lung cancer is diagnosed and managed day-to-day, which may help improve future care.
This trial tests a quality-of-life support program meant to help people with early-stage lung cancer think through their treatment choices. It may help you feel more informed and more confident about deciding between treatments like surgery and SBRT.
Hear when a new Lung cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.